BEGHETTO, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 6.857
EU - Europa 4.589
AS - Asia 3.583
SA - Sud America 425
Continente sconosciuto - Info sul continente non disponibili 124
AF - Africa 67
OC - Oceania 4
Totale 15.649
Nazione #
US - Stati Uniti d'America 6.701
IT - Italia 1.858
GB - Regno Unito 1.058
CN - Cina 1.038
SG - Singapore 1.008
SE - Svezia 442
HK - Hong Kong 371
VN - Vietnam 335
BR - Brasile 329
DE - Germania 298
TR - Turchia 228
FI - Finlandia 177
BD - Bangladesh 176
UA - Ucraina 176
FR - Francia 148
RU - Federazione Russa 114
KR - Corea 107
IN - India 105
CA - Canada 76
NL - Olanda 65
BG - Bulgaria 61
MX - Messico 39
AR - Argentina 35
ID - Indonesia 33
PL - Polonia 25
IQ - Iraq 24
ES - Italia 21
LT - Lituania 21
IE - Irlanda 19
IR - Iran 19
PK - Pakistan 18
BE - Belgio 17
CO - Colombia 17
SA - Arabia Saudita 15
ZA - Sudafrica 15
IL - Israele 14
CH - Svizzera 13
JP - Giappone 13
EC - Ecuador 12
SI - Slovenia 12
AT - Austria 11
EU - Europa 11
CL - Cile 9
CR - Costa Rica 9
MA - Marocco 9
TH - Thailandia 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
JM - Giamaica 8
MY - Malesia 8
PH - Filippine 8
EG - Egitto 7
NG - Nigeria 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
GR - Grecia 6
JO - Giordania 6
PE - Perù 6
RO - Romania 6
VE - Venezuela 6
BY - Bielorussia 5
DK - Danimarca 5
KE - Kenya 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
AU - Australia 4
DO - Repubblica Dominicana 4
HN - Honduras 4
KZ - Kazakistan 4
NP - Nepal 4
PA - Panama 4
RS - Serbia 4
TW - Taiwan 4
UY - Uruguay 4
AL - Albania 3
GE - Georgia 3
GT - Guatemala 3
SN - Senegal 3
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CU - Cuba 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MG - Madagascar 2
NI - Nicaragua 2
PT - Portogallo 2
QA - Qatar 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BZ - Belize 1
CI - Costa d'Avorio 1
Totale 15.523
Città #
Southend 781
Santa Clara 778
Singapore 677
Ashburn 598
Woodbridge 461
Fairfield 389
Chandler 385
Hong Kong 364
Jacksonville 324
San Jose 314
Hefei 285
Ann Arbor 251
Houston 241
Beijing 236
Nyköping 235
Dearborn 223
Wilmington 182
Milan 176
Rome 172
Council Bluffs 151
London 151
Cambridge 143
Seattle 139
Dallas 132
Izmir 123
Los Angeles 118
Helsinki 110
Seoul 105
Ho Chi Minh City 95
The Dalles 84
New York 82
Buffalo 75
Naples 73
Hanoi 72
Princeton 67
Modena 58
Sofia 58
Chicago 57
Eugene 57
Frankfurt am Main 57
San Diego 56
Lauterbourg 48
Shanghai 44
Munich 38
Bari 36
Moscow 34
Palermo 33
São Paulo 33
Bologna 32
Florence 32
Des Moines 30
Columbus 26
Da Nang 26
Orem 26
Chennai 23
Atlanta 22
Turin 21
Brescia 20
Philadelphia 20
Catania 19
Guangzhou 19
Mexico City 18
Dublin 17
Mumbai 17
Toronto 17
Boardman 16
Brussels 16
Elk Grove Village 16
Warsaw 16
Falkenstein 15
Jakarta 15
Memphis 15
Montreal 15
Brooklyn 14
Nanjing 14
Phoenix 14
Salt Lake City 14
Augusta 13
Bremen 13
Haiphong 13
San Mateo 13
Turku 13
Baghdad 12
Johannesburg 12
Manassas 12
Stockholm 12
Boston 11
Genoa 11
Ottawa 11
Redwood City 11
Denver 10
Ferrara 10
Kent 10
Kunming 10
Mashhad 10
Norwalk 10
Parma 10
Shenzhen 10
Tokyo 10
Amsterdam 9
Totale 10.222
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.895
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles 378
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 367
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients 350
Long-term psychometric outcomes of facial lipoatrophy therapy: Forty-eight-week observational, nonrandomized study 316
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 315
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 312
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 310
Detectable HIV viral load is associated with metabolic syndrome 302
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 300
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 293
Associatioin of epicardial adipose tissue with incident coronary heart disease and death in HIV infected patients. 284
Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection 282
Prediction of hard cardiovascular events in HIV patients 280
A randomized, controlled trial to evaluate change in cardiometabolic and endothelial function in HIV-infected patients with optimal viral suppression on Darunavir/ritonavir monotherapy vs. triple-therapy. 279
Severity of lipodystrophy is associated with decreased health-related quality of life 276
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 273
Effectiveness and durability of polyacrylamide hydrogel injections for treating HIV-related facial lipoatrophy 272
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 260
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 259
Age-related comorbidities in people living with HIV 256
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 248
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV 248
Randomized Trial to Evaluate Cardiometabolic and Endothelial Function in Patients with Plasma HIV-1 RNA Suppression Switching to Darunavir/Ritonavir with or without Nucleoside Analogues 236
ISS-NIA ITALIAN COHORT: NEW ANTI-HIV INHIBITORS IN PATIENTS EXPERIENCED TO IP, NRTI, NNRTI. 234
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 232
Does lipodistrophy affect quality of life? 229
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 228
Effectiveness and long-term durability of autologous fat transplant for HIV-related face lipoatrophy. 227
Body Image perception in HIV infected women with body fat redistribution. 225
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 224
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 221
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 221
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study 215
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 211
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 210
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 206
How do frailty mediate pathway leading to disability 205
Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the italian version of assessment of body change and distress questionnaire 203
È possibile un counselling HIV su internet? 201
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 199
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 199
Virologic failure and metabolic syndrome in patients with HIV infection 196
Validity of body image perception in women with HIV. 193
Virologic failure and metabolic syndrome in patients with HIV infection 188
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial 187
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 182
Prevalence and risk factors of pubic lipomas in HIV-infected patients 180
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 179
Relapse of HIV-related buffalo hump after liposuction 177
Prospective, 48 weeks follow up, multidisciplinary interventionalstudy to assess improvement of adherence in people with lipodistrophy. 176
Qual è il rapporto tra qualità di vita e lipodistrofia 169
HIV counselling looks for new target and methods web versus face to face counselling 167
Ruolo della chirurgia plastica nel trattamento della sindrome da ridistribuzione del tessuto adiposo 161
Lipodystrophy and quality of life: a prospective study 160
Nuovi obiettivi e strumenti di lavoro nel counselling HIV: studio prospettico osservazionale del counselling informatico versus il counselling vis a vis 151
Metabolic and anthropometric alterations in a population of HIV infected patients with a high prevalence of lipodystrophy: associations with HCV coinfection 150
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 141
Gender differences in depression evolution in a cohort of patients attendine a metabolic clinic for lipodystrophy management 141
Lipodistrophy is related to adherence to antiretroviral therapy (ARV) 136
HIV counselling and prevention on the WEB 134
Totale 15.649
Categoria #
all - tutte 52.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022893 0 136 62 104 23 43 34 76 95 66 142 112
2022/20231.398 140 121 111 109 121 178 38 152 180 45 107 96
2023/20241.039 60 71 81 130 165 79 91 98 34 49 60 121
2024/20252.816 113 77 60 224 589 403 214 130 336 97 259 314
2025/20264.666 309 222 473 544 541 346 508 268 498 420 281 256
2026/2027477 165 312 0 0 0 0 0 0 0 0 0 0
Totale 15.649